Molecules to Medicine
A Clinical Trial and Suicide Leave Many Questions: Part 3: Conflict of Interest
December 18th, 2012 |
6
We’ve touched on some of the many disturbing things that happened during the clinical trial on which Dan Markingson committed suicide. In my first post, I asked how a psychotic, homicidal patient who was involuntarily hospitalized in a psychiatric hospital could give an informed consent for participation in a clinical trial. There appeared to have [...]
Keep reading »
See what we're tweeting about
